Caricamento...
Low prevalence of bone mineral density testing in patients with systemic lupus erythematosus and glucocorticoid exposure
Patients with systemic lupus erythematosus (SLE) have an increased risk of developing osteoporosis and fractures due to systemic inflammation and glucocorticoids (GCs). Professional organizations recommend bone mineral density (BMD) testing in SLE patients on GCs, especially within 6 months of initi...
Salvato in:
| Pubblicato in: | Lupus |
|---|---|
| Autori principali: | , , , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
2020
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7933066/ https://ncbi.nlm.nih.gov/pubmed/33307984 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/0961203320979735 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|